Compound ID | 2008
Class: Tetracycline
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Protein synthesis inhibitor. Binds reversibly to the bacterial 30S ribosomal subunit preventing the aminoacyl tRNA from binding to the A site |
| Description: | Semisynthetic derivative of the natural product aureomycin from Streptomyces aureofaciens which exhibited higher potency, favourable pharmacological profile, and better solubility |
| Year first mentioned: | 1953 |
| Highest development stage: | Approved by FDA in 1954 |
| Development status: | Approved |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/54675776 |
| Guide to Pharmacology: | tetracycline |
| Citation: | https://doi.org/10.1111/j.1749-6632.2011.06354.x |